Live Breaking News & Updates on Pharma mar

Stay informed with the latest breaking news from Pharma mar on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pharma mar and stay connected to the pulse of your community

Short Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Increases By 38.7%

Short Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Increases By 38.7%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

France , Spain , Ireland , Italy , Germany , United-states , Pharma-mar , Pharma-mar-company-profile , Get-free-report , Pharma-mar-daily ,

Short Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Increases By 38.7%

Short Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Increases By 38.7%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Italy , Germany , France , Spain , Ireland , United-states , Pharma-mar , Get-free-report , Pharma-mar-daily ,

Pharma Mar (OTCMKTS:PHMMF) Shares Down 6.4%

Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report)’s stock price was down 6.4% during mid-day trading on Friday . The company traded as low as $43.28 and last traded at $43.28. Approximately 150 shares traded hands during mid-day trading, an increase of 704% from the average daily volume of 19 shares. The stock had previously […]

Germany , Italy , France , Spain , Ireland , United-states , Pharma-mar , Get-free-report , Pharma-mar-daily , Otcmkts-phmmf , Phmmf , Medical

Pharma Mar sees highest patent filings and grants during July in Q3 2023

Pharma Mar sees highest patent filings and grants during July in Q3 2023
pharmaceutical-technology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-technology.com Daily Mail and Mail on Sunday newspapers.

Morocco , United-states , Poland , Globaldata-databook , Pharma-mar , European-patent-office , Company-profiles , Company-profile , Pfizer , Poland-pl-patent-office , Johnson , Patent-office

Pharma Mar (OTCMKTS:PHMMF) Hits New 52-Week Low at $32.10

Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $32.10 and last traded at $32.10, with a volume of 0 shares traded. The stock had previously closed at $32.10. Pharma Mar Stock Performance The firm’s 50-day simple moving average […]

Germany , Italy , France , Spain , Ireland , United-states , Pharma-mar , Get-free-report , Pharma-mar-daily , Otcmkts-phmmf , Phmmf , Medical

Selpercatinib Significantly Improves PFS, Responses in Advanced RET+ Medullary Thyroid Cancer

Selpercatinib resulted in a statistically significant improvement in progression-free survival and overall response rate compared with cabozantinib or vandetanib in patients with advanced, multikinase inhibitor–naïve, RET-mutant medullary thyroid cancer, according to interim findings from the phase 3 LIBRETTO-531 trial.

France , Villejuif , France-general- , French , Pharma-mar , Julien-hadoux , Gustave-roussy , Eli-lilly , Selpercatinib-retevmo , Novartis , Published-october , Selpercatinib

Dostarlimab Plus Chemo Continues to Demonstrate Strong Clinical Efficacy in Advanced NSCLC

Dostarlimab plus chemotherapy elicited a higher objective response rate and showcased a numerical improvement in overall survival compared with pembrolizumab and chemotherapy in patients with treatment-naïve, nonsquamous non–small cell lung cancer.

Spain , Switzerland , Barcelona , Comunidad-autonoma-de-cataluna , Denmark , Copenhagen , Køavn- , Eli-lilly , Roche-genentech , Daiichi-sankyo , Noemi-reguart , Pharma-mar

Pharma Mar (OTCMKTS:PHMMF) Reaches New 52-Week Low at $32.10

Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report)’s share price hit a new 52-week low during trading on Monday . The company traded as low as $32.10 and last traded at $32.10, with a volume of 4 shares traded. The stock had previously closed at $32.10. Pharma Mar Price Performance The stock has a 50 […]

Ireland , Italy , Germany , Spain , France , United-states , Pharma-mar , Pharma-mar-company-profile , Get-free-report , Pharma-mar-daily , Otcmkts-phmmf , Phmmf

BME Launches IBEX速 ESG Index Family To Promote Sustainability

BME Launches IBEX速 ESG Index Family To Promote Sustainability
mondovisione.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondovisione.com Daily Mail and Mail on Sunday newspapers.

Spain , Sabadell , Comunidad-autonoma-de-cataluna , Switzerland , Spanish , Swiss , Catalana-occidente , Pharma-mar , Marion-leslie , Acciona-energ , Merlin-properties , Head-index-services-spain

Pharma Mar (OTCMKTS:PHMMF) Hits New 1-Year Low at $33.34

Pharma Mar (OTCMKTS:PHMMF) Hits New 1-Year Low at $33.34
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Spain , Germany , Italy , United-states , France , Ireland , Pharma-mar , Get-free-report , Pharma-mar-daily ,